^
Association details:
| Biomarker: | PDZK1IP1 expression |
|---|---|
| Cancer: | Pancreatic Cancer |
| Drug: | gemcitabine (DNA synthesis inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
1655P - Nampt inhibitors re-sensitize MAP17 expressing pancreas tumors
Published date:
10/16/2023
Excerpt:
...MAP17-expressing PC cells showed better response to gemcitabine, 5-FU, cisplatin and osimertinib, as well as resistance to docetaxel, bortezomib and ixazomib.
